NASDAQ Affirms Trading Halt on KaloBios Pharma (KBIO)
Tweet
Share
E-mail
Get Alerts KBIO Hot Sheet
Join SI Premium – FREE
The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) at 06:48:07 Eastern Time for "additional information requested" from the company at a last price of $23.59.
Trading will remain halted until KaloBios Pharmaceuticals, Inc. has fully satisfied Nasdaq’s request for additional information.
The halt occurred following this morning's arrest of CEO Martin Shkreli following allegations of securities fraud.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pelican Way Research shorts Hyliion Holdings (HYLN) on VFG deal concerns
- Roku (ROKU) Halted, News Pending
- SPS Commerce hires Morgan Stanley, explores sale - Reuters
Create E-mail Alert Related Categories
Short Sales, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
